Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Procyon
AddedFeb 20, 2024
UpdatedJul 5, 2026
Procyon

Procyon

Public

Procyon Corporation develops and markets medical products for skin care through its subsidiary, Amerx Health Care Corp.

HQ
Clearwater, FL, US
Founded
1987
Overview
Compare
Employees

Procyon Corporation is a holding company for Amerx Health Care Corp. The Company produces medical products for the treatment of various skin problems.

Amerx markets its products to health care institutions and retailers.

Procyon - Similar Companies

Procyrion logo

Procyrion

Amexdrug logo

Amexdrug

amexdrug.com

Proterixbio logo

Proterixbio

Phylogix logo

Phylogix

Enhance Skin Products logo

Enhance Skin Products

Microdermis logo

Microdermis

Journey Medical logo

Journey Medical

Dermal Life logo

Dermal Life

Proteotech logo

Proteotech

The Radiant Creations Group logo

The Radiant Creations Group

Encore Dermatology logo

Encore Dermatology

PluroGen Therapeutics logo

PluroGen Therapeutics

Omni Bioceutical Innovations logo

Omni Bioceutical Innovations

Sonoma Pharmaceuticals logo

Sonoma Pharmaceuticals

Provell Pharmaceuticals logo

Provell Pharmaceuticals

provellpharma.com

Procyon - Quick Facts

Who are Procyon's competitors?

Companies similar to Procyon include Procyrion, Amexdrug, Proterixbio and Phylogix.

When was Procyon founded?

Procyon was founded in 1987.

Where is Procyon's headquarters located?

Procyon's headquarters is located in Clearwater, FL, US.

How many employees does Procyon have?

Procyon has 18 employees as of Feb 5, 2024.

Procyon - Classification

Industry
  • Retail
Ownership
  • Public
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Products
  • Skin Care
Tags
  • Biotech
Unique IDs
  • secCik: 0000812306
  • ticker: PCYN
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 541700Scientific Research and Development Services
  • 456110Pharmacies and Drug Retailers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 5912Drug Stores and Proprietary Stores
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4772Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores